Commerzbank Aktiengesellschaft’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,238
Closed -$809K 1006
2016
Q4
$809K Buy
+7,238
New +$871K 0.01% 493
2016
Q1
Sell
-3,501
Closed -$243K 1170
2015
Q4
$243K Buy
+3,501
New +$285K ﹤0.01% 1036
2013
Q4
Sell
-48,321
Closed -$838K 1439
2013
Q3
$838K Sell
48,321
-1,724
-3% -$19.8K ﹤0.01% 894
2013
Q2
$441K Buy
+50,045
New +$443K ﹤0.01% 1106

Other funds holding GWPH

Commerzbank Aktiengesellschaft's GWPH Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2017, closing a stake of 7,238 shares — an estimated $809K sold.

Commerzbank Aktiengesellschaft first reported a position in GWPH in Q2 2013 and held it in 4 quarters. The position peaked at $838K in Q3 2013. 179 funds tracked by Wall St. Rank hold GWPH as of Q1 2017.

  • Commerzbank Aktiengesellschaft reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 7,238 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2017, an estimated $809K.
  • Commerzbank Aktiengesellschaft first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2013 and held it in 4 quarters.
  • Commerzbank Aktiengesellschaft's GW Pharmaceuticals Plc American Depositary Shares position peaked at $838K in Q3 2013.
  • 179 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.